Literature DB >> 23237700

OPTN/SRTR 2011 Annual Data Report: lung.

M Valapour1, K Paulson, J M Smith, M I Hertz, M A Skeans, B M Heubner, L B Edwards, J J Snyder, A K Israni, B L Kasiske.   

Abstract

Lungs are allocated in part based on the Lung Allocation Score (LAS), which considers risk of death without transplant and posttransplant. Wait-list additions have been increasing steadily after an initial decline following LAS implementation. In 2011, the largest number of adult candidates were added to the waiting list in a single year since 1998; donation and transplant rates have been unable to keep pace with wait-list additions. Candidates aged 65 years or older have been added faster than candidates in other age groups. After an initial decline following LAS implementation, wait-list mortality increased to 15.7 per 100 wait-list years in 2011. Short- and long-term graft survival improved in 2011; 10-year graft failure fell to an all-time low. Since 1998, the number of new pediatric (aged 0-11 years) candidates added yearly to the waiting list has declined. In 2011, 19 pediatric lung transplants were performed, a transplant rate of 34.7 per 100 wait-list years. The percentage of patients hospitalized before transplant has not changed. Both graft and patient survival have continued to improve over the past decade. Posttransplant complications for pediatric lung transplant recipients, similar to complications for adult recipients, include hypertension, renal dysfunction, diabetes, bronchiolitis obliterans syndrome, and malignancy. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23237700     DOI: 10.1111/ajt.12024

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  39 in total

Review 1.  Revascularization of decellularized lung scaffolds: principles and progress.

Authors:  Collin T Stabler; Shimon Lecht; Mark J Mondrinos; Ernesto Goulart; Philip Lazarovici; Peter I Lelkes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

2.  Acute In Vivo Evaluation of the Pittsburgh Pediatric Ambulatory Lung.

Authors:  Alexandra G May; Ryan A Orizondo; Brian J Frankowski; Peter D Wearden; William J Federspiel
Journal:  ASAIO J       Date:  2019 May/Jun       Impact factor: 2.872

3.  Fourteen Day In Vivo Testing of a Compliant Thoracic Artificial Lung.

Authors:  David J Skoog; Joshua R Pohlmann; David S Demos; Christopher N Scipione; Amit Iyengar; Rebecca E Schewe; Ahmed B Suhaib; Kelly L Koch; Keith E Cook
Journal:  ASAIO J       Date:  2017 Sep/Oct       Impact factor: 2.872

4.  The use of optical clearing and multiphoton microscopy for investigation of three-dimensional tissue-engineered constructs.

Authors:  Elizabeth A Calle; Sam Vesuna; Sashka Dimitrievska; Kevin Zhou; Angela Huang; Liping Zhao; Laura E Niklason; Michael J Levene
Journal:  Tissue Eng Part C Methods       Date:  2014-01-16       Impact factor: 3.056

5.  The Implantable Pediatric Artificial Lung: Interim Report on the Development of an End-Stage Lung Failure Model.

Authors:  Fares Alghanem; Ryan P Davis; Benjamin S Bryner; Hayley R Hoffman; John Trahanas; Marie S Cornell; Alvaro Rojas-Peña; Robert H Bartlett; Ronald B Hirschl
Journal:  ASAIO J       Date:  2015 Jul-Aug       Impact factor: 2.872

Review 6.  Treatment of pulmonary arterial hypertension in children.

Authors:  Heiner Latus; Tammo Delhaas; Dietmar Schranz; Christian Apitz
Journal:  Nat Rev Cardiol       Date:  2015-02-03       Impact factor: 32.419

7.  Influence of specific thoracic donor therapy on kidney donation and long-term kidney graft survival.

Authors:  María A Ballesteros; Jorge Duerto Álvarez; Luis Martín-Penagos; Emilio Rodrigo; Manuel Arias; Eduardo Miñambres
Journal:  J Nephrol       Date:  2016-11-09       Impact factor: 3.902

8.  How to establish a successful ex vivo lung perfusion program.

Authors:  George Makdisi; Thomas C Wozniak
Journal:  Ann Transl Med       Date:  2017-05

9.  Massive donor transfusion potentially increases recipient mortality after lung transplantation.

Authors:  Catherine F Borders; Yoshikazu Suzuki; Jared Lasky; Christian Schaufler; Djamila Mallem; James Lee; Kevin Carney; Scarlett L Bellamy; Christian A Bermudez; A Russell Localio; Jason D Christie; Joshua M Diamond; Edward Cantu
Journal:  J Thorac Cardiovasc Surg       Date:  2016-12-15       Impact factor: 5.209

Review 10.  Coming to terms with tissue engineering and regenerative medicine in the lung.

Authors:  Y S Prakash; Daniel J Tschumperlin; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-07       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.